+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-12-24Number of Pages: 85

Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Global Hospital Acquired Disease Testing Market Share, by Geography, 2014–2023 (US$ Mn)
2.2 Global Hospital Acquired Disease Testing Market, by Test, 2014 (US$ Mn)
2.3 Hospital Acquired Disease Testing Market Snapshot

Chapter 3 Hospital Acquired Disease Testing Market – Industry Analysis
3.1 Introduction
3.2 Market Drivers
     3.2.1 Establishment of government guidelines and code for prevention of HAIs
     3.2.2 Increase in prevalence of HAIs and rise in the number of drug resistant pathogens
3.3 Restraints
     3.3.1 Stringent regulations and guidance framework
     3.3.2 Lack of controlling authorities and control programs in less developed regions
3.4 Opportunity
     3.4.1 Passage of the Patient Care and Affordable Care Act in the U.S.
     3.4.2 Technological development in the field of molecular diagnostics
3.5 Porter’s Five Forces Analysis
3.6 Market Attractiveness Analysis– Hospital Acquired Disease Testing Market, by Geography (2014) (Value %) 

Chapter 4 Market Segmentation – By Test
4.1 Introduction
4.2 Global Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
     4.2.1 Global Urinary Tract Infection Testing Market Revenue, 2013–2023 (US$ Mn)
     4.2.2 Global Surgical Site Infection Testing Market Revenue, 2013–2023 (US$ Mn)
     4.2.3 Global Pneumonia Infection Testing Market Revenue, 2013–2023 (US$ Mn)
     4.2.4 Global Bloodstream Infection Testing Market Revenue, 2013–2023 (US$ Mn)
     4.2.5 Global Others Infection Testing Market Revenue, 2013–2023 (US$ Mn)

Chapter 5 Market Segmentation – By Geography
5.1 Introduction
5.2 Global Hospital Acquired Disease Testing Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.3 North America Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.4 North America Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.5 Europe Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.6 Europe Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.7 Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.8 Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.9 Latin America Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.10 Latin America Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)
5.11 Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Country, 2013–2023 (US$ Mn)
5.12 Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Test, 2013–2023 (US$ Mn)

Chapter 6 Recommendations

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 Alere, Inc. 
7.3 Becton, Dickinson and Company
7.4 bioMérieux SA
7.5 F. Hoffmann-La Roche Ltd.
7.6 Hologic, Inc.
7.7 QIAGEN
7.8 Siemens Healthcare
7.9 Diatherix Laboratories, Inc.
7.10 Meridian Bioscience, Inc.
7.11 Thermo Fisher Scientific, Inc. (Life Technologies Corporation)
7.12 Cepheid, Inc.

 


 
 
Back To Top